ʻO ka weheweheʻana
ʻO Bromoaacetotrile a iʻole cyanomometl bromide heʻano bortide he mea koʻikoʻi ma ka synthesis lāʻau lapaʻau. ʻO ka maʻemaʻe kiʻekiʻe a me ka maikaʻi o kā mākou huahana e hana ai iā lākou no nāʻoihana aʻo lāʻau lapaʻau eʻimi nei e hoʻomohala i nā maʻi a me nāʻano o nā maʻi a me nā kūlana.
E like me ke kī nui ma ka synthesis o ka synthesis o Paxlovid, kā mākou bromoatetonitrile e pāʻani ana i kahi hana koʻikoʻi i loko o kēia hana kaumaha. Uaʻike nuiʻiaʻo Paxloden no kona hopena i ka mālamaʻana i nā maʻi covid-19. Ma ka hāʻawiʻana i kahi kumu hilinaʻi, kiʻekiʻe-kiʻekiʻe o ka bromoatetonitrile
Hanaʻia kā mākou Bromoaattentitrile i nā kūlana kiʻekiʻe kiʻekiʻe loa, e hōʻoiaʻiʻo ana i ka noʻonoʻo a me ka hoʻomaʻemaʻe mai ka batch i ka batch. Hoʻomaopopo mākou i ka mea nui o ka maikaʻi a me ka hilinaʻi i kaʻoihana lāʻau lapaʻau, a ua hana mākou e hāʻawi i nā huahana e hālāwai ai me nā mea kūʻai aku.
Koho iā mākou
ʻO Jdk i nā hale hana mua o nā papa mua a me nā mea hoʻokele waiwai kūpono, e hōʻoia ana i ka nui o ka pono o ka API i kauʻia. ʻO ka hui loea e hoʻopiʻi iā R & D o ka huahana. E kū'ē iā lāua, keʻimi nei mākou no CMM & CDMO ma ka hale kūʻai home a me ka mākeke honua.